Serum free prostate specific antigen: Isoenzymes in benign hyperplasia and cancer of the prostate

The Prostate

Volumn 27, Issue 4, 1995, Pages 212-219

  Huber, Peter R ^a   Schmid, Hans‐Peter ^b   Mattarelli, Gianfranco ^b   Strittmatter, Bernadette ^a   van Steenbrugge, Gert Jan ^d   Maurer, Andreas ^c  

^a Kantonsspital Basel   (Switzerland)

^b Division of Urology   (Switzerland)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

isoenzymes; microheterogeneity; prostate specific antigen; PSA

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ISOENZYME; PROSTATE SPECIFIC ANTIGEN; SIALIDASE;

ARTICLE; BLOOD LEVEL; CHROMATOFOCUSING; CLINICAL ARTICLE; CULTURE MEDIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; ISOELECTRIC POINT; PH; PHOSPHORYLATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; CULTURE MEDIA; HUMAN; HYDROGEN-ION CONCENTRATION; IMMUNOASSAY; ISOELECTRIC FOCUSING; ISOENZYMES; MALE; NEURAMINIDASE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0028826456     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.2990270406     Document Type: Article

References (25)

1. A Kallikrein‐like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein
2. Seminal vesicle secreted proteins and their reactions during gelation and liquefaction of human semen
3. A complex between prostate‐specific antigen and α1‐antichymotrypsin is the major form of prostate‐specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer
4. In vivo and in vitro complex formation of prostate specific antigen with α1‐antichymotrypsin
5. Interaction of prostate specific antigen with alpha‐1‐antichymotrypsin
6. Binding of serum prostatic antigen to concanavalin A in patients with cancer or hyperplasia of the prostate
7. Prostate specific antigen of human cancer patients
8. Occurrence of the Y determinant on the N‐glycosid carbohydrate units of human γ‐seminoprotein
9. Human prostate‐specific antigen: structural and functional similarity with serine proteases
10. Prostate specific antigen. Experimental and clinical observations
11. Variations in 3H‐diisopropylphosphate binding proteins in human seminal plasma
12. Detection of desialylated forms of human chorionic gonadotropin
13. Concanavalin A affinity chromatography of human serum gonadotropins: evidence for changes of carbohydrate structure in different clinical conditions
14. Less acidic forms of luteneizing hormone are associated with lower testosterone secretion in men on haemodyalysis treatment
15. Differential alpha‐fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels
16. Datura stramonium agglutinin‐reactive α‐fetoprotein isoforms in hepatocellular carcinoma and other tumors
17. The LNCAP cell line—a new model for studies on human prostate carcinoma
18. LNCAP model of human prostatic carcinoma
19. Monoclonal antibody (F5) to human prostate antigen
20. Ratio of polyclonal‐monoclonal prostate‐specific antigen levels. Discrimination of nodal status in prostate tumors that produce low marker levels
21. PSA‐con A binding ratio in benign prostate hyperplasia and prostate cancer
22. Double‐label time resolved immunofluorometric assay of prostate‐specific antigen and of its complex with α1‐antichymotrypsin
23. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis
24. Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia
25. Lectins as indicators of disease‐associated glycoforms